Trials / Conditions / TSC1
TSC1
3 registered clinical trials studyying TSC1.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in T NCT05103358 | Aadi Bioscience, Inc. | Phase 2 |
| Completed | Everolimus for Cancer With TSC1 or TSC2 Mutation NCT02201212 | Dana-Farber Cancer Institute | Phase 2 |
| Approved For Marketing | Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Gene NCT03817515 | Aadi Bioscience, Inc. | — |